228 related articles for article (PubMed ID: 33272888)
1. Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy.
Chi Z; Zhao W; Li JW; Liu H; Shao C; Zhao H; Gui-Qiang W
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101563. PubMed ID: 33272888
[TBL] [Abstract][Full Text] [Related]
2. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Diktas H; Karacaer Z; Özturk II; Cicek H
Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
[TBL] [Abstract][Full Text] [Related]
3. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
4. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
6. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
[TBL] [Abstract][Full Text] [Related]
7. A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.
Li L; Ye Y; Ran Y; Liu S; Tang Q; Liu Y; Liao X; Zhang J; Xiao G; Lu J; Zhang G; He Q; Hu S
Medicine (Baltimore); 2021 Apr; 100(17):e25581. PubMed ID: 33907107
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
[TBL] [Abstract][Full Text] [Related]
9. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
[TBL] [Abstract][Full Text] [Related]
10. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
[TBL] [Abstract][Full Text] [Related]
11. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
[TBL] [Abstract][Full Text] [Related]
13. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA.
Yao K; Wang J; Wang L; Xia J; Yan X; Wu W; Liu J; Wang L; Yin S; Tong X; Ding W; Huang R; Wu C
J Med Virol; 2022 Feb; 94(2):659-666. PubMed ID: 34499353
[TBL] [Abstract][Full Text] [Related]
14. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Wu Z; Dong X; Wang G; Zhao H;
J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
[TBL] [Abstract][Full Text] [Related]
15. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.
Gao S; Li XY; Fan YC; Sun FK; Han LY; Li F; Ji XF; Wang K
J Gastroenterol Hepatol; 2017 Jan; 32(1):215-220. PubMed ID: 27207016
[TBL] [Abstract][Full Text] [Related]
16. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
[TBL] [Abstract][Full Text] [Related]
17. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
[TBL] [Abstract][Full Text] [Related]
19. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
[TBL] [Abstract][Full Text] [Related]
20. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection.
Barut S; Gemici Ü; Güneş F; Demir O; Duygu F
J Med Virol; 2017 Nov; 89(11):1952-1957. PubMed ID: 28618019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]